Education
About Us
Working with TipRanks
Follow Us
Atara Biotherapeutics (GB:0HIY)
LSE:0HIY
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 128.94M | $ 8.57M | $ 63.57M | $ 20.34M | $ 0.00 |
| Gross Profit | $ 107.93M | $ -313.00K | $ 49.01M | $ 8.96M | $ -9.87M |
| Operating Income | $ -83.44M | $ -276.01M | $ -280.51M | $ -340.46M | $ -309.05M |
| EBITDA | $ -83.44M | $ -266.00M | $ -213.72M | $ -331.12M | $ -296.74M |
| Net Income | $ -85.40M | $ -276.13M | $ -2.28B | $ -3.40B | $ -3.07B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 42.50M | $ 51.73M | $ 242.82M | $ 371.07M | $ 500.66M |
| Total Assets | $ 109.10M | $ 165.50M | $ 376.42M | $ 468.13M | $ 588.12M |
| Total Debt | $ 29.91M | $ 57.87M | $ 71.70M | $ 25.52M | $ 13.04M |
| Net Debt | $ 4.88M | $ 32.03M | $ -21.24M | $ -80.57M | $ -187.36M |
| Total Liabilities | $ 206.38M | $ 264.74M | $ 249.78M | $ 188.51M | $ 125.78M |
| Stockholders' Equity | $ -97.28M | $ -99.23M | $ 126.64M | $ 279.61M | $ 462.34M |
| Cash Flow | |||||
| Free Cash Flow | $ -68.96M | $ -194.20M | $ -274.62M | $ -231.10M | $ -185.27M |
| Operating Cash Flow | $ -68.72M | $ -192.98M | $ -270.43M | $ -220.52M | $ -180.76M |
| Investing Cash Flow | $ 8.62M | $ 123.87M | $ 202.96M | $ 22.26M | $ -120.73M |
| Financing Cash Flow | $ 59.28M | $ 2.01M | $ 53.08M | $ 103.94M | $ 427.57M |